title: A primer of amyloid nomenclature.
abstract: The increasing knowledge of the exact biochemical nature of the localized and systemic amyloid disorders has made a logical and easily understood nomenclature absolutely necessary. Such a nomenclature, biochemically based, has been used for several years but the current literature is still mixed up with many clinical and histochemically based designations from the time when amyloid in general was poorly understood. All amyloid types are today preferably named by their major fibril protein. This makes a simple and rational nomenclature for the increasing number of amyloid disorders known in humans and animals.
authors: Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden. per.westermark@genpat.uu.se
authors: Per
authors: P
authors: Westermark
authors: Merrill D
authors: MD
authors: Benson
authors: Joel N
authors: JN
authors: Buxbaum
authors: Alan S
authors: AS
authors: Cohen
authors: Blas
authors: B
authors: Frangione
authors: Shu-Ichi
authors: S
authors: Ikeda
authors: Colin L
authors: CL
authors: Masters
authors: Giampaolo
authors: G
authors: Merlini
authors: Maria J
authors: MJ
authors: Saraiva
authors: Jean D
authors: JD
authors: Sipe
mesh_terms: D000682:Amyloid / Q000145:classification* / Q000378:metabolism; D000686:Amyloidosis / Q000145:classification* / Q000378:metabolism / Q000473:pathology; D000818:Animals; D006801:Humans
chemical_list: D000682:Amyloid